Načítá se...
Targeting met mediated epithelial-mesenchymal transition in the treatment of breast cancer
Mesenchymal epithelial transition factor receptor (Met) is a receptor tyrosine kinase that plays a critical role in promoting cancer cell malignant progression. Met is activated by its ligand hepatocyte growth factor (HGF). HGF-dependent Met activation plays an important role in stimulating epitheli...
Uloženo v:
| Vydáno v: | Clin Transl Med |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer Berlin Heidelberg
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4883993/ https://ncbi.nlm.nih.gov/pubmed/26932375 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40169-014-0030-5 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|